Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Yu Hikosaka"'
Autor:
Yoshinaga, Aoyama, Takeyasu, Katada, Masaki, Saito, Tomonori, Tsuchiya, Toru, Nishido, Akira, Kato, Takahiro, Shibata, Tadashi, Shibata, Futoshi, Teranishi, Shoko, Sakamoto, Keiko, Mita, Shoji, Karamatsu, Yu, Hikosaka, Tsutomu, Nishida
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(3)
We report a case of colostomy-free, long-term survival following 5-FU/CDDP for the local recurrence of anal cancer after chemoradiation therapy(CRT). The patient was a 48-year-old woman who was diagnosed with cStage ⅢA anal cancer. She was treated
Autor:
Masaki, Saito, Futoshi, Teranishi, Tadashi, Shibata, Takeyasu, Katada, Takahiro, Shibata, Yoshinaga, Aoyama, Akira, Kato, Toru, Nishido, Tomonori, Tsuchiya, Shoko, Sakamoto, Keiko, Mita, Shoji, Karamatsu, Yu, Hikosaka, Tsutomu, Nishida
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(2)
A 71-year-old man underwent low anterior resection for rectal cancer 10 years prior. He underwent resection of liver metastasis once and that of lung metastases multiple times after the primary surgery. Computed tomography revealed a mass measuring 2
Autor:
Yoshitaka Fujii, Hidefumi Sasaki, Masayuki Shitara, Katsuhiro Okuda, Keisuke Yokota, Motoki Yano, Yu Hikosaka, Satoru Moriyama
Publikováno v:
Neurology and Clinical Neuroscience. 3:167-172
Background Since its introduction, tacrolimus has been widely used in myasthenia gravis (MG) patients. However, the correlation between the blood concentration level of the drug, the change in anti-acetylcholine receptor (AChR) antibody and the effec
Autor:
Ayumi Suzuki, Yoshitaka Fujii, Hidefumi Sasaki, Masayuki Shitara, Katsuhiro Okuda, Tsutomu Tatematsu, Yu Hikosaka, Satoru Moriyama, Motoki Yano
Publikováno v:
Lung Cancer. 86:174-179
Objectives Thymic carcinoma is a rare mediastinal neoplasm and little is known about its tumorigenesis. There is no effective treatment except for complete resection, and the prognosis of advanced cases is poor. To identify the mutations associated w
Autor:
Masayuki Shitara, Yu Hikosaka, Tsutomu Tatematsu, Yoshitaka Fujii, Satoru Moriyama, Motoki Yano, Ayumi Suzuki, Katsuhiro Okuda, Hidefumi Sasaki
Publikováno v:
Biomedical Reports
Recent study results have demonstrated that a subclass of apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC) cytidine deaminase may induce mutation clusters in various types of cancer. From the Cancer Genome Altas, an APOBEC mu
Autor:
Motoki Yano, Satoru Moriyama, Yu Hikosaka, Katsuhiro Okuda, Hidefumi Sasaki, Tsutomu Tatematsu, Ayumi Suzuki, Yoshitaka Fujii, Masayuki Shitara
Publikováno v:
Oncology Letters
Prognosis following recurrence subsequent to complete resection of non-small-cell lung cancer (NSCLC) is considered a multifactorial process dependent on clinicopathological, biological and treatment characteristics. Gefitinib was approved for lung c
Autor:
Yoshitaka Fujii, Yu Hikosaka, Tsutomu Tatematsu, Masayuki Shitara, Katsuhiro Okuda, Motoki Yano, Hidefumi Sasaki, Satoru Moriyama
Publikováno v:
Surgery Today. 44:1817-1822
The purpose of this study was to determine the clinicopathological findings and prognosis of small-sized anterior mediastinal tumors (SSAMTs). A retrospective study was conducted on 43 patients who underwent surgery between January 1989 and December
Autor:
Ayumi Suzuki, Yoshitaka Fujii, Masayuki Shitara, Motoki Yano, Katsuhiro Okuda, Yu Hikosaka, Hidefumi Sasaki, Satoru Moriyama
Publikováno v:
International Journal of Molecular Medicine. 31:1135-1138
Nuclear factor (erythroid derived 2)-like 2 (NRF2, gene name NFE2L2) gene mutations have been previously identified in lung cancers. The constitutive activation of NRF2 resulting from gene mutations has been correlated with the poor prognosis of pati
Autor:
Magali Irla, Yu Hikosaka, Stéphanie Hugues, Jason Gill, Hamish S. Scott, Walter Reith, Georg A. Holländer, Takeshi Nitta, Yousuke Takahama, Ifor R. Williams, François-Xavier Hubert
Publikováno v:
Immunity, Vol. 29, No 3 (2008) pp. 451-63
Publons
Publons
Medullary thymic epithelial cells (mTECs) are specialized for inducing central immunological tolerance to self-antigens. To accomplish this, mTECs must adopt a mature phenotype characterized by expression of the autoimmune regulator Aire, which activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5969b077e1583e7e4556dad7220c53cf
https://ora.ox.ac.uk/objects/uuid:e2eab4b9-a4e5-4add-ae03-c2be17afb379
https://ora.ox.ac.uk/objects/uuid:e2eab4b9-a4e5-4add-ae03-c2be17afb379
Autor:
Masayuki Shitara, Katsuhiro Okuda, Yoshitaka Fujii, Yu Hikosaka, Ayumi Suzuki, Motoki Yano, Hidefumi Sasaki, Satoru Moriyama
Publikováno v:
Biomedical Reports. 1:93-96
An imbalance in immune regulation affects tumor-specific T-cell immunity in the cancer microenvironment and reshapes tumor progression and metastasis. Blockade of interactions of immune function mediates anti-tumor activity in preclinical models. In